Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,021 to 2,040 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| MIR183 microRNA 183 | 406959 HGNC:31554 | 0 | 0 | 0 | 0 | 1,174 | 3,243 |
| PTPRN protein tyrosine phosphatase receptor type N | 5798 HGNC:9676 | 1 | 238 | 0 | 0 | 1,442 | 3,241 |
| MIR10A microRNA 10a | 406902 HGNC:31497 | 0 | 0 | 0 | 0 | 1,300 | 3,238 |
| UBE2I ubiquitin conjugating enzyme E2 I | 7329 HGNC:12485 | 1 | 113 | 0 | 0 | 1,903 | 3,237 |
| ARF1 ARF GTPase 1 | 375 HGNC:652 | 1 | 82 | 0 | 0 | 2,017 | 3,235 |
| MMP11 matrix metallopeptidase 11 | 4320 HGNC:7157 | 1 | 45 | 0 | 0 | 1,360 | 3,235 |
| SERPINB2 serpin family B member 2 | 5055 HGNC:8584 | 1 | 145 | 0 | 0 | 1,602 | 3,233 |
| SCN9A sodium voltage-gated channel alpha subunit 9 | 6335 HGNC:10597 | 1 | 50 | 90 | 1,313 | 1,318 | 3,231 |
| DNAJB1P1 DNAJB1 pseudogene 1 | 171221 HGNC:24988 | 0 | 0 | 0 | 0 | 1,959 | 3,230 |
| TACSTD2 tumor associated calcium signal transducer 2 | 4070 HGNC:11530 | 1 | 124 | 2 | 156 | 1,195 | 3,230 |
| EIF2AK4 eukaryotic translation initiation factor 2 alpha kinase 4 | 440275 HGNC:19687 | 1 | 24 | 0 | 0 | 2,284 | 3,229 |
| CNP 2',3'-cyclic nucleotide 3' phosphodiesterase | 1267 HGNC:2158 | 1 | 37 | 0 | 0 | 2,096 | 3,228 |
| POU2F2 POU class 2 homeobox 2 | 5452 HGNC:9213 | 1 | 20 | 0 | 0 | 1,756 | 3,227 |
| WNT4 Wnt family member 4 | 54361 HGNC:12783 | 1 | 190 | 0 | 0 | 2,197 | 3,227 |
| CD8B CD8 subunit beta | 926 HGNC:1707 | 1 | 197 | 0 | 0 | 2,371 | 3,225 |
| TAL1 TAL bHLH transcription factor 1, erythroid differentiation factor | 6886 HGNC:11556 | 1 | 58 | 0 | 0 | 2,325 | 3,225 |
| CEACAM1 CEA cell adhesion molecule 1 | 634 HGNC:1814 | 1 | 217 | 0 | 0 | 1,608 | 3,222 |
| WNT2 Wnt family member 2 | 7472 HGNC:12780 | 1 | 48 | 0 | 0 | 2,102 | 3,221 |
| KRT16 keratin 16 | 3868 HGNC:6423 | 1 | 26 | 0 | 0 | 2,120 | 3,220 |
| MIR130A microRNA 130a | 406919 HGNC:31514 | 0 | 0 | 0 | 0 | 1,202 | 3,220 |
Code
curl "https://conductscience.org/api/genes/v1?page=102"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=102
{
"data": {
"total": 193990,
"results": [
{
"id": "406959",
"title": "MIR183: microRNA 183",
"summary": "NCBI Gene 406959. 0 proteins, 0 patents, 0 drugs, 0 trials, 1,174 NIH grants and 3,243 papers.",
"record": "/library/genes/406959",
"gene_id": 406959,
"symbol": "MIR183",
"name": "microRNA 183",
"hgnc_id": "HGNC:31554",
"counts": {
"proteins": 0,
"patents": 0,
"drugs": 0,
"trials": 0,
"grants": 1174,
"papers": 3243
}
},
{
"id": "5798",
"title": "PTPRN: protein tyrosine phosphatase receptor type N",
"summary": "NCBI Gene 5798. 1 protein, 238 patents, 0 drugs, 0 trials, 1,442 NIH grants and 3,241 papers.",
"record": "/library/genes/5798",
"gene_id": 5798,
"symbol": "PTPRN",
"name": "protein tyrosine phosphatase receptor type N",
"hgnc_id": "HGNC:9676",
"counts": {
"proteins": 1,
"patents": 238,
"drugs": 0,
"trials": 0,
"grants": 1442,
"papers": 3241
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=103",
"request_id": "Kf0opkVXPk2Kjk8N"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant